A patient fills a prescription for a 30-day supply of amlodipine 10 mg. Two days later,the patient brings in a prescription for diltiazem 30 mg from their primary care provider. Which of the following rejection messages is the pharmacy technician most likely to receive?

This message typically indicates that the medication requires approval from the insurance company before it can be dispensed, often due to cost considerations or specific clinical guidelines. However, neither amlodipine nor diltiazem generally requires prior authorization in standard situations, making this option unlikely in this scenario.

This rejection message indicates that the specific National Drug Code (NDC) for the medication is not included in the patient's insurance plan. While it is possible for either drug to be non-covered, the situation presented is more indicative of therapeutic duplication rather than a coverage issue.

This message is received when a patient attempts to refill a prescription before the allotted time has passed, which does not apply here since the patient is filling a new prescription for diltiazem two days after obtaining amlodipine. Therefore, this option is also unlikely.